CS logo
small CS logo
Trovare Clinical Research

Bakersfield, California, United States

About Trovare Clinical Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Trovare Clinical Research


During the past decade, Trovare Clinical Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
2008-07-17
2023-12-16
Active, not recruiting
220
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
2016-04-30
2022-12-13
Completed
578
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2018-08-10
2024-03-31
Active, not recruiting
135
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
2020-10-26
2026-12-18
Recruiting
946

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Trovare Clinical Research" #1 sponsor was "Baudax Bio" with 3 trials, followed by "Heron Therapeutics" with 2 trials sponsored, "Allena Pharmaceuticals" with 1 trials sponsored, "Avenue Therapeutics, Inc." with 1 trials sponsored and "Cali Pharmaceuticals LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Trovare Clinical Research" #1 collaborator was "Lotus Clinical Research, LLC" with 2 trials as a collaborator and "TesoRx Pharma, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Trovare Clinical Research


According to Clinical.Site data, the most researched conditions in "Trovare Clinical Research" are "Pain, Post-operative" (3 trials), "Postoperative Pain" (2 trials), "Bladder Cancer" (1 trials), "Bladder Cancer Cell Transitional" (1 trials) and "Bunion" (1 trials). Many other conditions were trialed in "Trovare Clinical Research" in a lesser frequency.

Clinical Trials Intervention Types at Trovare Clinical Research


Most popular intervention types in "Trovare Clinical Research" are "Drug" (10 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Bupivacaine HCl" (2 trials), "HTX-011" (2 trials), "Intranasal Dexmedetomidine" (2 trials) and "Intranasal Placebo" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Trovare Clinical Research


The vast majority of trials in "Trovare Clinical Research" are 11 trials for "All" genders.

Clinical Trials Status at Trovare Clinical Research


Currently, there are NaN active trials in "Trovare Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Trovare Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Trovare Clinical Research, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status